Purification of the Constitutive Nitric Oxide Synthase

  • Edward P. Garvey
Part of the Methods in Molecular Biology™ book series (MIMB, volume 100)

Abstract

Constitutive nitric oxide synthase (NOS) exists as two isoforms: endothelial (e) and neuronal (n) (reviewed in ref. 1). The first reports on the purification of eNOS and nNOS were by Schmidt et al. (2) and Bredt and Snyder (3), respectively; all subsequent reports have been modifications of these procedures. The purification of both of the constitutive isoforms and the inducible (i) NOS depends on the use of 2′,5′-adenosine diphosphate (ADP) affinity chromatography. The 2′,5′-ADP ligand is a structural mimic of the cofactor nicotinamide adenine dinucleotide phosphate (NADPH) that is required for NOS activity. Therefore, the biospecific elution is accomplished by the presence of NADPH. The purification of both constitutive isoforms, unlike iNOS, also depends on a second affinity-chromatography step, calmodulin (CaM)-affinity chromatography. Exogenously-added CaM is essential for both purified eNOS and nNOS activity. In the presence of calcium, CaM binds both constitutive isoforms in a tight (Kd ∼ 10 nM) but reversible complex, thereby activating NOS. In contrast, CaM binds to iNOS in the absence of added calcium and dissociates only in the presence of a protein denaturant. Thus, during the 2′,5′-ADP-affinity step, CaM is removed from eNOS and nNOS, but not iNOS. The binding of eNOS and nNOS to the CaM resin is performed in the presence of calcium, and elution of NOS is achieved by the absence of calcium and presence of ethylenediaminetetraacetic acid (EDTA) and high salt. Depending on the source of enzyme, near homogenous NOS is often obtained by utilizing these two affinity steps.

Keywords

Sucrose Glycerol EDTA Fractionation CaCl2 

References

  1. 1.
    Stuehr, D. J. and Griffith, O. W. (1992) Mammalian nitric oxide synthases. Adv. Enzymol. Relat. Areas Mol. Biol. 65, 287–346.PubMedGoogle Scholar
  2. 2.
    Schmidt, H. H. H. W., Pollock, J. S., Nakane, M., Gorsky, L. D., Forstermann, U., and Murad, R. (1991) Purification of a soluble isoform of guanyl cylcase-activating-factor synthase. Proc. Natl. Acad. Sci. USA 88, 365–369.PubMedCrossRefGoogle Scholar
  3. 3.
    Bredt, D. S. and Synder, S. H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682–685.PubMedCrossRefGoogle Scholar
  4. 4.
    Michel, T., Li, G. K., and Busconi, L. (1993) Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 90, 6252–6256.PubMedCrossRefGoogle Scholar
  5. 5.
    Garvey, E. P., Tuttle, J. V., Covington, K., Merrill, B. M., Wood, E. R., Baylis, S. A., and Charles, I. G. (1994) Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch. Biochem. Biophys. 311, 235–241.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1998

Authors and Affiliations

  • Edward P. Garvey
    • 1
  1. 1.Glaxo WellcomeResearch Triangle Park

Personalised recommendations